Africa: First mRNA Flu Shot Approved By FDA Bodes Well for Improving Drugs of the Future – Though a Few Hurdles Remain Before mNRA Can Move Beyond Vaccines
Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often not directly transferable to another….
